ELIXIR MD Inc., a medical technology company pioneering proprietary technologies and treatment protocols for post-surgical recovery today announced a strategic partnership with H/K/B Cosmetic Surgery, ...
Encellin, a biotechnology company pioneering Encapsulated Cell Replacement Therapy (ENCRT), today announced interim clinical results from its ongoing Phase 1 investigational trial (NCT06408311) in ...
Purality Health's 5000 IU Micelle Formula Draws Consumer Interest as Winter Deficiency Research and Absorption Technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback